217 related articles for article (PubMed ID: 10958260)
1. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants.
Toni C; Perugi G; Frare F; Mata B; Akiskal HS
Acta Psychiatr Scand; 2004 Aug; 110(2):130-7. PubMed ID: 15233713
[TBL] [Abstract][Full Text] [Related]
3. [Panic disorder and agoraphobia: what is effective?].
Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
[TBL] [Abstract][Full Text] [Related]
4. Comorbid cannabis use and panic disorder: short term and long term follow-up study.
Dannon PN; Lowengrub K; Amiaz R; Grunhaus L; Kotler M
Hum Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 14994319
[TBL] [Abstract][Full Text] [Related]
5. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
Hantouche EG; Bouhassira M; Lancrenon S
Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
[TBL] [Abstract][Full Text] [Related]
6. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
[TBL] [Abstract][Full Text] [Related]
7. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.
Marchesi C; De Panfilis C; Cantoni A; Fontò S; Giannelli MR; Maggini C
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1240-5. PubMed ID: 16678956
[TBL] [Abstract][Full Text] [Related]
8. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
9. Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?
Dusseldorp E; Spinhoven P; Bakker A; van Dyck R; van Balkom AJ
Psychother Psychosom; 2007; 76(3):154-61. PubMed ID: 17426414
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
Pecknold JC; Luthe L; Iny L; Ramdoyal D
J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
[TBL] [Abstract][Full Text] [Related]
11. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
Humble M; Wistedt B
Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
[TBL] [Abstract][Full Text] [Related]
12. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
13. Agoraphobia and panic. Prospective-longitudinal relations suggest a rethinking of diagnostic concepts.
Wittchen HU; Nocon A; Beesdo K; Pine DS; Hofler M; Lieb R; Gloster AT
Psychother Psychosom; 2008; 77(3):147-57. PubMed ID: 18277061
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.
Nagy LM; Krystal JH; Charney DS; Merikangas KR; Woods SW
J Clin Psychopharmacol; 1993 Feb; 13(1):16-24. PubMed ID: 8098050
[TBL] [Abstract][Full Text] [Related]
15. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
Montejo AL; Llorca G; Izquierdo JA; Rico-Villademoros F
J Clin Psychiatry; 2001; 62 Suppl 3():10-21. PubMed ID: 11229449
[TBL] [Abstract][Full Text] [Related]
16. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
Noyes R; Garvey MJ; Cook BL; Samuelson L
J Clin Psychiatry; 1989 May; 50(5):163-9. PubMed ID: 2715139
[TBL] [Abstract][Full Text] [Related]
17. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
[TBL] [Abstract][Full Text] [Related]
18. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of panic disorder during pregnancy: a 7-year naturalistic follow-up study.
Dannon PN; Iancu I; Lowengrub K; Grunhaus L; Kotler M
Clin Neuropharmacol; 2006; 29(3):132-7. PubMed ID: 16772811
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.
Perugi G; Frare F; Toni C; Tusini G; Vannucchi G; Akiskal HS
Eur Arch Psychiatry Clin Neurosci; 2010 Oct; 260(7):553-60. PubMed ID: 20238120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
